Company news

Heartbeam, Inc. news in 2025

Heartbeam, Inc.'s news releases, calls and decks from 2025, newest first.

View company

HeartBeam Receives FDA Clearance for First-Ever, Cable-Free Synthesized 12-Lead ECG for At-Home Arrhythmia Assessment

December 10, 2025

HeartBeam Provides Update on Regulatory Path Following FDA Decision on 12-Lead ECG Synthesis Software Application

November 26, 2025

HeartBeam (BEAT) Reports Q3 2025 Results as FDA Review Nears Completion and Commercial Readiness Accelerates

November 14, 2025

HeartBeam Reports Third Quarter 2025 Results

November 13, 2025

HeartBeam to Host Third Quarter 2025 Results Conference Call on Thursday, November 13, 2025 at 4: 30 p.m. Eastern Time

October 30, 2025

HeartBeam Teams Up With HeartNexus to Deliver Cardiologist-Level ECG Insights Anytime, Anywhere

October 28, 2025

HeartBeam (BEAT) Reports Study Showing Comparable Accuracy Between HeartBeam System and Standard 12-Lead ECG in Detecting Arrhythmias

September 9, 2025

HeartBeam’s Deep Learning Algorithms Demonstrate High Rates of Accuracy for Detecting Arrhythmias

September 8, 2025

HeartBeam (NASDAQ: BEAT) to Present at Three September Investor Conferences

August 29, 2025

HeartBeam to Participate at Upcoming Industry and Investor Conferences, September 4-10, 2025

August 28, 2025

HeartBeam's (NASDAQ: BEAT) IP Momentum Continues with New Patents Advancing 3D ECG Technology

August 22, 2025

HeartBeam Reports Second Quarter 2025 Results

August 13, 2025

HeartBeam to Host Second Quarter 2025 Results Conference Call on Wednesday, August 13, 2025 at 4: 30 p.m. Eastern Time

July 30, 2025

HeartBeam Wins Industry Innovation Award for Advancing Remote Cardiac Care With Groundbreaking ECG Technology

July 22, 2025

HeartBeam to Present at the iAccess Alpha Virtual Best Ideas Summer Conference on June 24, 2025

June 17, 2025

HeartBeam Reports First Quarter 2025 Results

May 13, 2025

HeartBeam Announces Two New U.S. Patents, Powering Forward Its Robust Patent Portfolio

May 6, 2025

HeartBeam Appoints CEO Robert Eno to Board of Directors to Support U.S. Commercialization and Growth

May 5, 2025

HeartBeam to Host First Quarter 2025 Results Conference Call on Tuesday, May 13, 2025 at 4: 30 p.m. Eastern Time

May 1, 2025

HeartBeam Successfully Meets Clinical Endpoints in Pivotal Study for its Groundbreaking 12-Lead ECG Synthesis Technology

April 29, 2025

HeartBeam and AccurKardia Announce Strategic Collaboration to Advance Cardiac Monitoring Innovation

April 24, 2025

HeartBeam Reports Fourth Quarter and Full Year 2024 Results

March 13, 2025

HeartBeam to Participate at Upcoming Conferences in Dana Point, California, March 16-21, 2025

March 6, 2025

HeartBeam to Host Fourth Quarter Full Year 2024 Results Conference Call on Thursday, March 13, 2025 at 4: 30 p.m. Eastern Time

February 27, 2025

HeartBeam Announces Exercise and Closing of Underwriter’s Over-Allotment Option for Public Offering of Common Stock

February 25, 2025

HeartBeam Announces Pricing of $10.0 Million Underwritten Public Offering of Common Stock

February 12, 2025

HeartBeam Achieves Major Milestone with FDA Submission for its Groundbreaking 12-Lead ECG Synthesis Software

January 28, 2025

Calls in 2025

Decks in 2025